{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:14:57Z","timestamp":1768439697716,"version":"3.49.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/md.0000000000001933","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T12:51:44Z","timestamp":1447246304000},"page":"e1933","source":"Crossref","is-referenced-by-count":20,"title":["Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis"],"prefix":"10.1097","volume":"94","author":[{"given":"Em\u00edlia","family":"M\u00e1csai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Benke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210309","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"R2-16-20210309","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2013.09.011","article-title":"Survival trends in ESRD patients compared with the general population in the United States.","volume":"63","author":"van Walraven","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R3-16-20210309","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-013-2966-1","article-title":"Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.","volume":"56","author":"Schroijen","year":"2013","journal-title":"Diabetologia"},{"key":"R4-16-20210309","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ndt\/gfq386","article-title":"NECOSAD Study Group. Sex differences in the impact of diabetes on mortality in chronic dialysis patients.","volume":"26","author":"Carrero","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R5-16-20210309","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.5604\/17322693.1076915","article-title":"Mortality predictor pattern in hemodialysis and peritoneal dialysis diabetic patients in 4-year prospective observation.","volume":"67","author":"Madziarska","year":"2013","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"R7-16-20210309","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1177\/089686080702702s29","article-title":"Can we overcome the predestined poor survival of diabetic patients Perspectives from pre- and post-dialysis.","volume":"27","author":"Kim","year":"2007","journal-title":"Perit Dial Int"},{"key":"R8-16-20210309","doi-asserted-by":"crossref","first-page":"e80486","DOI":"10.1371\/journal.pone.0080486","article-title":"Diabetic patients could do as well as non-diabetic patients without inflammation on peritoneal dialysis.","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"R9-16-20210309","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.","volume":"16","author":"Meerwaldt","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R10-16-20210309","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000339282","article-title":"Skin autofluorescence: a pronounced marker of mortality in hemodialysis patients.","volume":"2","author":"Gerrits","year":"2012","journal-title":"Nephron Extra"},{"key":"R11-16-20210309","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/1744-9987.12160","article-title":"Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis.","volume":"18","author":"Kimura","year":"2014","journal-title":"Ther Apher Dial"},{"key":"R12-16-20210309","doi-asserted-by":"crossref","first-page":"e83084","DOI":"10.1371\/journal.pone.0083084","article-title":"Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis.","volume":"8","author":"den Dekker","year":"2013","journal-title":"PLoS One"},{"key":"R13-16-20210309","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","article-title":"Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms.","volume":"3","author":"Stirban","year":"2013","journal-title":"Mol Metab"},{"key":"R14-16-20210309","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/cclm-2012-0832","article-title":"Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review.","volume":"52","author":"Arsov","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"R15-16-20210309","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ndt\/gfn634","article-title":"AGEs autofluorescence and renal function.","volume":"24","author":"Gerrits","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R16-16-20210309","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.metabol.2008.05.016","article-title":"Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.","volume":"57","author":"Ueno","year":"2008","journal-title":"Metabolism"},{"key":"R17-16-20210309","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cardfail.2008.03.008","article-title":"Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.","volume":"14","author":"Hartog","year":"2008","journal-title":"J Card Fail"},{"key":"R18-16-20210309","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00296-007-0408-4","article-title":"Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods.","volume":"28","author":"Matsumoto","year":"2007","journal-title":"Rheumatol Int"},{"key":"R19-16-20210309","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/aor.12205","article-title":"Skin and plasma autofluorescence during hemodialysis: a pilot study.","volume":"38","author":"Graaff","year":"2014","journal-title":"Artif Organs"},{"key":"R20-16-20210309","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11255-013-0597-6","article-title":"Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis.","volume":"46","author":"Mac-Way","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R21-16-20210309","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s11255-011-0097-5","article-title":"Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients.","volume":"44","author":"Oleniuc","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"R22-16-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","article-title":"Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.","volume":"224","author":"Jiang","year":"2012","journal-title":"Atherosclerosis"},{"key":"R23-16-20210309","first-page":"CR","article-title":"Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis.","volume":"16","author":"Skubala","year":"2010","journal-title":"Med Sci Monit"},{"key":"R24-16-20210309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/193229680800200407","article-title":"Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9).","volume":"2","author":"Gerrits","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"R25-16-20210309","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.","volume":"31","author":"Gerrits","year":"2008","journal-title":"Diab Care"},{"key":"R26-16-20210309","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1556\/APhysiol.99.2012.2.15","article-title":"Factors influencing skin auto-fluorescence of patients with peritoneal dialysis Hungarian.","volume":"99","author":"Macsai","year":"2012","journal-title":"Acta Physiol Hung"},{"key":"R28-16-20210309","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/089686080602600502","article-title":"Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis.","volume":"26","author":"Lo","year":"2006","journal-title":"Perit Dial Int"},{"key":"R30-16-20210309","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1177\/193229680900300629","article-title":"Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution.","volume":"3","author":"Holmes","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"R31-16-20210309","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2215\/CJN.05350709","article-title":"Tissue-advanced glycation end product concentration in dialysis patients.","volume":"5","author":"McIntyre","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-16-20210309","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ndt\/gfm148","article-title":"Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.","volume":"22","author":"Schmitt","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R33-16-20210309","doi-asserted-by":"crossref","first-page":"e65592","DOI":"10.1371\/journal.pone.0065592","article-title":"Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes.","volume":"8","author":"Smit","year":"2013","journal-title":"PLoS One"},{"key":"R34-16-20210309","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1556\/OH.2012.29453","article-title":"Skin autofluorescence measurement in the clinical practice of diabetology and nephrology Hungarian.","volume":"153","author":"Macsai","year":"2012","journal-title":"Orv Hetil"},{"key":"R35-16-20210309","first-page":"629","article-title":"A comparison of medium-term survival between peritoneal dialysis and haemodialysis in accordance with the initial vascular access.","volume":"33","author":"Garcia-Canton","year":"2013","journal-title":"Nefrologia"},{"key":"R36-16-20210309","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11255-014-0870-3","article-title":"Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis.","volume":"47","author":"Siriopol","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R37-16-20210309","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.ajkd.2009.05.014","article-title":"Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.","volume":"54","author":"Han","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R38-16-20210309","first-page":"663","article-title":"Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence Curr Opin Nephrol H","volume":"22","author":"Mehrotra","year":"2013","journal-title":"ypertens"},{"key":"R39-16-20210309","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis.","volume":"3","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R41-16-20210309","first-page":"450","article-title":"Should nonglucose containing peritoneal dialysis solutions be used in all patients to avoid long-term membrane injury Semin D","volume":"24","author":"Blake","year":"2011","journal-title":"ial"},{"key":"R42-16-20210309","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.","volume":"29","author":"Paniagua","year":"2009","journal-title":"Perit Dial Int"},{"key":"R43-16-20210309","first-page":"336","article-title":"Patients on peritoneal dialysis with type 2 diabetes have poorer outcomes than non-diabetics due to preceding cardiovascular comorbidity.","volume":"29","author":"Portoles","year":"2009","journal-title":"Nefrologia"},{"key":"R44-16-20210309","doi-asserted-by":"crossref","first-page":"e83799","DOI":"10.1371\/journal.pone.0083799","article-title":"Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study.","volume":"8","author":"Tanaka","year":"2013","journal-title":"PLoS One"},{"key":"R45-16-20210309","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2215\/CJN.09510913","article-title":"Skin autofluorescence and all-cause mortality in stage 3 CKD.","volume":"9","author":"Fraser","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R46-16-20210309","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/ATVBAHA.114.303378","article-title":"Skin autofluorescence associates with vascular calcification in chronic kidney disease.","volume":"34","author":"Wang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R47-16-20210309","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"and the CKD Prognosis Consortium: decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.","volume":"25","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"R48-16-20210309","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/089686080902900604","article-title":"Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.","volume":"29","author":"Schilte","year":"2009","journal-title":"Perit Dial Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:53:16Z","timestamp":1620960796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201511110-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":44,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001933","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}